CareDx
US Supreme Court Declines to Hear CareDx Organ Transplant Patent Infringement Case
CareDx had petitioned the US Supreme Court to hear a patent infringement case brought against Natera and Eurofins Viracor.
SEC Concludes CareDx Investigation, Recommends No Enforcement Action
The SEC informed CareDx in a letter that it had concluded an investigation into the company's accounting and public reporting practices.
Public Comment Period Opened for Draft LCD on Solid Organ Transplant Molecular Testing
The proposed revisions to the LCD underlying two prior billing article revisions aims to clarify past LCD language without changing coverage.
CareDx Eyes Wider Coverage, Adoption of Transplant Tests Despite Medicare Billing Article Impact
Premium
Adapting to the coverage decision put a dent in test volumes, but the firm has implemented needed changes and expects to see gains toward the end of the year.
District Court Issues Injunction Prohibiting False Advertising in Natera-CareDx Legal Row
The court forbade Natera from making nine claims and CareDx from making two claims related to separate studies featuring the companies' kidney allograft testing platforms.
May 10, 2023
Apr 3, 2023
360Dx Top 30 Rebounds 2 Percent in March
Jan 9, 2023
CareDx Preliminary Q4 Revenues up 4 Percent
Dec 6, 2022